121 related articles for article (PubMed ID: 8675954)
1. NMR study of dideoxynucleotides with anti-human immunodeficiency virus (HIV) activity.
Reddy DV; Jagannadh B; Kunwar AC
J Biochem Biophys Methods; 1996 Feb; 31(3-4):113-21. PubMed ID: 8675954
[TBL] [Abstract][Full Text] [Related]
2. 1H NMR study of the sugar pucker of 2',3'-dideoxynucleosides with anti-human immunodeficiency virus (HIV) activity.
Jagannadh B; Reddy DV; Kunwar AC
Biochem Biophys Res Commun; 1991 Aug; 179(1):386-91. PubMed ID: 1883367
[TBL] [Abstract][Full Text] [Related]
3. NMR investigation on the structure and conformation of 3'-azido-2',3'-dideoxyribosylthymine (AZT), an inhibitor of the HIV (AIDS virus).
Swapna GV; Jagannadh B; Gurjar MK; Kunwar AC
Biochem Biophys Res Commun; 1989 Nov; 164(3):1086-92. PubMed ID: 2590188
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
[TBL] [Abstract][Full Text] [Related]
5. [Molecular and crystalline structure of 3'-methylamino-2',3'-dideoxyribosylthymine--a potential inhibitor of HIV].
Bochkarev AV; Ias'ko MV; Zhdanov AS; Fedorov II; Gurskaia GV
Bioorg Khim; 1992 Jul; 18(7):996-1001. PubMed ID: 1445432
[TBL] [Abstract][Full Text] [Related]
6. Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)hypoxanthine.
Liaw YC; Gao YG; Marquez VE; Wang AH
Nucleic Acids Res; 1992 Feb; 20(3):459-65. PubMed ID: 1741280
[TBL] [Abstract][Full Text] [Related]
7. Conformational properties of dinucleoside monophosphates in solution: dipurines and dipyrimidines.
Lee CH; Ezra FS; Kondo NS; Sarma RH; Danyluk SS
Biochemistry; 1976 Aug; 15(16):3627-39. PubMed ID: 952881
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.
Tan CK; Civil R; Mian AM; So AG; Downey KM
Biochemistry; 1991 May; 30(20):4831-5. PubMed ID: 1709809
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anti-HIV activity and stability studies of 3'-azido-2',3'-dideoxythymidine 5'-fluorophosphate.
Egron D; Arzumanov AA; Dyatkina NB; Krayevsky A; Imbach JL; Aubertin AM; Gosselin G; Périgaud C
Nucleosides Nucleotides; 1999; 18(4-5):983-4. PubMed ID: 10432725
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H
Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292
[TBL] [Abstract][Full Text] [Related]
11. Reduction of 3'-azido-3'-deoxythymidine (AZT) and AZT nucleotides by thiols. Kinetics and product identification.
Reardon JE; Crouch RC; St John-Williams L
J Biol Chem; 1994 Jun; 269(23):15999-6008. PubMed ID: 8206896
[TBL] [Abstract][Full Text] [Related]
12. Conformational properties of branched RNA fragments in aqueous solution.
Damha MJ; Ogilvie KK
Biochemistry; 1988 Aug; 27(17):6403-16. PubMed ID: 2464368
[TBL] [Abstract][Full Text] [Related]
13. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
[TBL] [Abstract][Full Text] [Related]
14. AZT 5'-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells.
Saiyed ZM; Gandhi NH; Nair MP
J Neurovirol; 2009 Jul; 15(4):343-7. PubMed ID: 19575326
[TBL] [Abstract][Full Text] [Related]
15. Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus.
Van Roey P; Salerno JM; Chu CK; Schinazi RF
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):3929-33. PubMed ID: 2726758
[TBL] [Abstract][Full Text] [Related]
16. The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2002 Apr; 76(7):3248-56. PubMed ID: 11884549
[TBL] [Abstract][Full Text] [Related]
17. New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
J Med Chem; 1992 May; 35(11):1938-41. PubMed ID: 1375962
[TBL] [Abstract][Full Text] [Related]
18. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state.
Painter GR; Andrews CW; Furman PA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):13-29. PubMed ID: 10772700
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
20. NMR docking of the competitive inhibitor thymidine 3',5'-diphosphate into the X-ray structure of staphylococcal nuclease.
Weber DJ; Serpersu EH; Gittis AG; Lattman EE; Mildvan AS
Proteins; 1993 Sep; 17(1):20-35. PubMed ID: 8234242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
